Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Mallinckrodt settles US opioid drug probe for 35 million dollar

      Mallinckrodt settles US opioid drug probe for 35 million dollar

      Ruby Khatun Khatun14 July 2017 9:23 AM IST
      Mallinckrodt Plc, one of the largest manufacturers of the generic opioid painkiller oxycodone, will pay $35 million to resolve allegations that it...
      Novartis readies for FDA review of 1 billion dollar CAR-T child cancer hope

      Novartis readies for FDA review of 1 billion dollar CAR-T child cancer hope

      Ruby Khatun Khatun14 July 2017 9:20 AM IST
      ZURICH: Two decades ago in a Memphis, Tenn., hospital lab, cancer scientist Dario Campana and his team were hunting for a new way to fight deadly...
      Nestle invests in microbiome-based diagnostics venture

      Nestle invests in microbiome-based diagnostics venture

      Ruby Khatun Khatun13 July 2017 2:19 PM IST
      ZURICH: Food group Nestle's health science business is investing 20 million euros ($22.8 million) in a joint venture with pharma and diagnostics...
      Biocon advances over 8 per cent, seeks USFDA approval for breast cancer drug

      Biocon advances over 8 per cent, seeks USFDA approval for breast cancer drug

      Ruby Khatun Khatun13 July 2017 2:19 PM IST
      Mumbai: The stock of Biocon Ltd. surged over 8% in the early morning trade on Wednesday, on the BSE ahead of the USFDA meet to discuss its breast...
      Pankaj Patel steps down as Cadila MD, son Sharvil to take over

      Pankaj Patel steps down as Cadila MD, son Sharvil to take over

      Ruby Khatun Khatun13 July 2017 2:19 PM IST
      New Delhi: Drug firm Cadila Healthcare said its chairman and MD Pankaj R Patel has stepped down as Managing Director of the company.His son Sharvil P...
      USFDA issues warning letter to Hyderabad-based Vista Pharma

      USFDA issues warning letter to Hyderabad-based Vista Pharma

      Ruby Khatun Khatun13 July 2017 2:19 PM IST
      Hyderabad: The USFDA has issued a warning letter to the manufacturing facility of the city-based Vista Pharmaceuticals Ltd, for "significant...
      Cosmetic Import Registration through Online Mode Only : CDSCO

      Cosmetic Import Registration through Online Mode Only : CDSCO

      Ruby Khatun Khatun13 July 2017 10:04 AM IST
      The Central Drugs Standard Control Organization (CDSCO), in pursuance of implementation of e-Governance has rolled out an online service for filing...
      FDA lifts hold on Concert Pharmas study testing hair loss drug

      FDA lifts hold on Concert Pharma's study testing hair loss drug

      Ruby Khatun Khatun13 July 2017 9:58 AM IST
      Concert Pharmaceuticals Inc said on Monday the U.S. Food and Drug Administration (FDA) lifted a clinical hold on a trial testing its therapy for...
      Zydus Cadila gets USFDA nod to market anti-dementia tablets

      Zydus Cadila gets USFDA nod to market anti-dementia tablets

      Ruby Khatun Khatun13 July 2017 9:19 AM IST
      New Delhi: Zydus Cadila has received final approval from the US health regulator to market Memantine Hydrochloride tablets, used to treat dementia, in...
      Piramal to expand pharma vertical presence in US, Europe

      Piramal to expand pharma vertical presence in US, Europe

      Ruby Khatun Khatun12 July 2017 2:39 PM IST
      New Delhi: Piramal Enterprises has said it is looking to expand presence of its pharma vertical in global markets such as the US, Europe and Japan...
      CDSCO allows relabeling old medicines stocks with revised MRPs

      CDSCO allows relabeling old medicines stocks with revised MRPs

      Ruby Khatun Khatun12 July 2017 10:59 AM IST
      Through a recent notice, Directorate of General of Health Services, Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and...
      Shire, Roche slug it out in billion-dollar haemophilia drug battle

      Shire, Roche slug it out in billion-dollar haemophilia drug battle

      Ruby Khatun Khatun12 July 2017 10:46 AM IST
      ZURICH: Swiss drugmaker Roche's bid to take a chunk of the $11 billion haemophilia drug market dominated by Shire took another blow with the Irish...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok